Ann: Phase 1/2 CHM CDH17 CAR-T GMP Manufacturing Complete, page-47

First 47 Last

Share
Profile

Follow
Cuprum29

1,104 Posts.

129

23/08/24

21:16

Post #: 75350557
Share

Originally posted by KrushingIt: ↑

At current levels, people stand to make multiples ie 10X if they buy shares now.

Suffice to say, I have put my money where my mouth is and have got a sizeable position.

Make no mistake:
a) the tech is excellent - CDH17 is a novel product developed by the pioneers in CAR T addressing major oncology markets with unmet needs; CLTX - CART has already shown strong efficacy signals in patients who were in 4th and 5th line therapy (65% of enrolled patients); NK platform potentially best in class with the MD Anderson trial being evaluated as a first line (triplet) therapy for AML
b) management is excellent - Rebecca and Paul are seasoned campaigners with a huge network;
c) multiple SP inflection points in the coming months including data read outs and FDA interactions;
d) I suspect the upcoming CR will be done at a significant premium to the current SP because pre approval was obtained via an EGM. Presumably this will happen shortly after the first patient is dosed with CHMs lead product (CDH17), which is any day now....and there are no major adverse events with the first patient.

Expand

"At current levels, people stand to make multiples ie 10X if they buy shares now."

That's what I thought when I bought at 2.9c
Then topped up at 1.7c
Watching this CR train wreck unfold, the smart ones may be the ones who hold out for 1.3c

CHM Price at posting: 1.6¢ Sentiment: Hold Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

IRE

Iress runs 'hot' for Wealth Within's stock tips

LU7

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Failure to report prompts ASX to impose multiple company suspensions

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 34 more messages in this thread...

First 47 Last

Add CHM (ASX) to my watchlist

(20min delay)
Last 1.4¢		Change 0.000(0.00%)		Mkt cap ! $12.67M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Ann: Phase 1/2 CHM CDH17 CAR-T GMP Manufacturing Complete, page-47

Iress runs 'hot' for Wealth Within's stock tips

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Failure to report prompts ASX to impose multiple company suspensions

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Featured News

Ann: Phase 1/2 CHM CDH17 CAR-T GMP Manufacturing Complete, page-47

Top Stories

Iress runs 'hot' for Wealth Within's stock tips

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Failure to report prompts ASX to impose multiple company suspensions

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Featured News